Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mifegyne (RU-486)].

J C Huber1

  • 1Klinische Abteilung für Gynäkologische Endokrinologie und Sterilitätsbehandlung, Universitäts-Klinik für Frauenheilkunde, Wien, Osterreich.

Gynakologisch-Geburtshilfliche Rundschau
|January 12, 2000
PubMed
Summary
This summary is machine-generated.

Mifegyne, an antigestagen, significantly impacts progesterone-dependent conditions. Proper indications and preconditions are crucial for its effective use in reproductive health.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parameters for calcium metabolism in women with polycystic ovary syndrome who undergo clomiphene citrate stimulation: a prospective cohort study.

European journal of endocrinology·2012
Same author

The association of variants in the FTO gene with longitudinal body mass index profiles in non-Hispanic white children and adolescents.

International journal of obesity (2005)·2011
Same author

Menopause redefined by the shift of paradigms.

Climacteric : the journal of the International Menopause Society·2011
Same author

Adrenaline: communication by electron emission. Effect of concentration and temperature. Product analysis.

Hormone molecular biology and clinical investigation·2011
Same author

Fourteen-year experience with laparoscopic ventrosuspension in patients with retroverted and retroflected uterus and pelvic pain syndromes.

Journal of minimally invasive gynecology·2010
Same author

Villous mucinous cystadenoma of the appendix in a postmenopausal woman.

JSLS : Journal of the Society of Laparoendoscopic Surgeons·2010
Same journal

[Pelvic floor in pregnancy and after child birth: recommendations of the AUG Committee. Expert correspondence no. 29 of 31 July 2009].

Gynakologisch-geburtshilfliche Rundschau·2010
Same journal

[Water birth: control of infection and contraindications. Expert correspondence no. 27 of 26 May 2009].

Gynakologisch-geburtshilfliche Rundschau·2010
Same journal

[Current treatment options in postpartum hemorrhage. Expert correspondence no. 26 of 26 May 2009. ].

Gynakologisch-geburtshilfliche Rundschau·2010
Same journal

[Off label use of drugs in obstetric gynecology. 23rd consensus of of experts 19 October 2007].

Gynakologisch-geburtshilfliche Rundschau·2010
Same journal

[Hyperreactive luteomas during pregnancy--symptoms and complications: a case report].

Gynakologisch-geburtshilfliche Rundschau·2010
Same journal

[Paget disease of the vulva: resolution after local treatment with imiquimod--report of a case and review of the literature].

Gynakologisch-geburtshilfliche Rundschau·2010
See all related articles

Area of Science:

  • Reproductive Endocrinology
  • Pharmacology

Context:

  • Progesterone is a key hormone in reproductive processes.
  • Antiprogesterone agents offer therapeutic potential.

Purpose:

  • To elucidate the influence of Mifegyne on progesterone-dependent situations.
  • To define the indications and preconditions for Mifegyne's use.

Summary:

  • Mifegyne, a potent antigestagen, demonstrates a profound ability to modulate progesterone-dependent physiological and pathological states.
  • Its clinical efficacy is contingent upon adherence to specific indications and established preconditions.

Impact:

  • Provides a framework for understanding Mifegyne's mechanism of action.
  • Informs clinical practice regarding the safe and effective application of antigestagens.